Article
Patient-derived response estimates from zero-passage organoids of luminal breast cancer
31 Dec 2024
Abstract excerpt
BACKGROUND: Primary luminal breast cancer cells lose their identity rapidly in standard tissue culture, which is problematic for testing hormone interventions and molecular pathways specific to the luminal subtype. Breast cancer organoids are thought to retain tumor characteristics better, but long-term viability of luminal-subtype cases is a persistent challenge. Our goal was to adapt short-term organoids of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
